Investing.com - Acadia Healthcare (NASDAQ: ACHC) reported third quarter EPS of $0.91, $0.01 better than the analyst estimate of $0.90. Revenue for the quarter came in at $815.6M versus the consensus estimate of $819.39M.
Guidance
Acadia Healthcare sees FY 2024 EPS of $3.35-$3.45 versus the analyst consensus of $3.52.
Acadia Healthcare sees FY 2024 revenue of $3.15B-$3.17B versus the analyst consensus of $3.20B.
Acadia Healthcare's stock price closed at $52.09. It is down -28.02% in the last 3 months and down -29.14% in the last 12 months.
Acadia Healthcare saw 4 positive EPS revisions and 8 negative EPS revisions in the last 90 days. See Acadia Healthcare's stock price’s past reactions to earnings here.
According to InvestingPro, Acadia Healthcare's Financial Health score is "good performance".
Check out Acadia Healthcare's recent earnings performance, and Acadia Healthcare's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar